Every material Form 8-K IPG Photonics has filed with the SEC since February 11, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
IPG Photonics reported third-quarter 2026 revenue of $287.5 million, up 15% from a year earlier, with net income of $20.3 million, or $0.47 per diluted share, compared with $7.5 million, or $0.18, in the prior-year quarter. The company guided fourth-quarter 2026 revenue to $265 million to $295 million and adjusted earnings per diluted share to $0.30 to $0.60, excluding the pending Lumibird Medical acquisition.
Q3 2026 revenue $287.5 million, up 15%; Advanced Solutions up 33% and Industrial Solutions up 12%
Q3 net income $20.3 million ($0.47 per diluted share) vs. $7.5 million ($0.18) a year earlier; adjusted EPS $0.61 vs. $0.35
Q4 2026 guidance: revenue $265 million to $295 million; adjusted EPS $0.30 to $0.60; adjusted EBITDA $33 million to $50 million
Lumibird Medical acquisition expected to close in the fourth quarter; guidance assumes no contribution from it
IPG Photonics signed a share purchase agreement on September 8, 2026, to acquire Lumibird Medical from Lumibird S.A. for €300 million in cash on a cash-free, debt-free basis, plus up to €50 million in contingent earn-out payments tied to 2026 and 2027 performance metrics. The company expects to fund the deal with cash on hand, and closing is expected in the fourth quarter of 2026, subject to French regulatory approvals and an AMF waiver.
Purchase price of €300 million on a cash-free, debt-free basis, payable in cash at closing, with customary adjustments
Earn-out of up to €50 million in additional cash based on certain 2026 and 2027 performance metrics
Closing subject to French foreign investment authorization and an AMF waiver from a mandatory buyout offer; expected in Q4 2026
Company secured a warranty and indemnity insurance policy covering certain breaches of seller representations
IPG Photonics reported second quarter 2026 revenue of $278.6 million, up 11% from a year earlier, and adjusted earnings of $0.58 per diluted share, up from $0.30. GAAP net income fell 21% to $5.2 million because of a $17.6 million impairment charge, so shareholders see both stronger adjusted results and weaker GAAP profit. The company also guided third quarter 2026 revenue to $265 million to $295 million.
Q2 2026 revenue $278.6 million, up 11% year over year; Industrial Solutions up 16%, Advanced Solutions down 9%
GAAP net income $5.2 million, or $0.12 per diluted share, versus $6.6 million, or $0.16, a year earlier; includes $17.6 million impairment charge
Adjusted EPS $0.58 versus $0.30 and adjusted EBITDA $48.5 million versus $31.5 million a year earlier
Q3 2026 guidance: revenue $265 million to $295 million, adjusted EPS $0.30 to $0.60, adjusted EBITDA $35 million to $51 million
IPG Photonics signed a put option agreement with Lumibird S.A. for the proposed acquisition of 100% of Lumibird Medical, a wholly owned subsidiary of the seller, for €300 million on a cash-free, debt-free basis, plus up to €50 million in contingent earnout tied to 2026 and 2027 performance. The company expects to fund the deal with cash on hand, and closing is expected in the fourth quarter of 2026, subject to a French works council consultation, French foreign direct investment authorization and other customary conditions. Shareholders should note the filing states the deal may not close on the anticipated timeline or at all.
Purchase price of €300 million on a cash-free, debt-free basis, payable in cash at closing, plus up to €50 million contingent earnout based on 2026 and 2027 metrics
Funding from cash on hand; closing expected in the fourth quarter of 2026
Put option becomes binding on IPG only after the seller delivers an exercise notice; if the seller does not exercise by the expiry date, it pays IPG €3.5 million
Lumibird Medical reported fiscal 2025 revenue of €112.2 million and IFRS EBITDA of €24.1 million, per the company's press release
IPG Photonics reported first-quarter 2026 revenue of $265.5 million, up 17% year over year, while GAAP net income fell 58% to $1.6 million and diluted EPS dropped to $0.04 from $0.09 after a $13.5 million litigation settlement expense. The company also agreed with TRUMPF Laser- und Systemtechnik SE to resolve and dismiss all patent litigation worldwide, and gave second-quarter 2026 revenue guidance of $260 million to $290 million.
Q1 2026 revenue was $265.5 million, up 17%; Industrial Solutions sales rose 21% to $227.6 million while Advanced Solutions fell 5%.
GAAP operating loss of $7.7 million, compared with operating income of $1.8 million a year earlier; net income was $1.6 million versus $3.8 million.
Operating expenses included a $13.5 million settlement of litigation matters; GAAP gross margin fell to 37.5% from 39.4%.
On May 5, 2026, IPG agreed with TRUMPF to resolve and dismiss all patent litigation worldwide; Q2 2026 guidance calls for adjusted EPS of $0.25 to $0.55.
IPG Photonics reported fourth-quarter 2025 revenue of $274.5 million, up 17% from a year earlier, and GAAP diluted EPS of $0.31, up from $0.18. Gross margin fell to 36.1% from 38.6% because of higher product costs and tariffs, and operating income dropped 76% to $3.3 million. The board authorized a new $100 million share repurchase program, and the company guided first-quarter 2026 revenue to $235 million to $265 million.
Q4 2025 revenue $274.5 million, up 17% year over year; GAAP diluted EPS $0.31 vs $0.18; adjusted EPS $0.46 vs $0.30
GAAP gross margin 36.1% vs 38.6%, reflecting higher product cost and tariffs; operating income $3.3 million vs $14.0 million
New share repurchase program authorized for up to $100 million of common stock
Q1 2026 guidance: revenue $235 million to $265 million; adjusted EPS $0.10 to $0.40; adjusted EBITDA $25 million to $40 million
IPG Photonics reported third-quarter 2025 results for the quarter ended September 30, 2025, with revenue up 8% year over year and GAAP net income of $7.5 million, compared with a net loss of $233.6 million a year earlier, which included divestiture and impairment charges. For the first nine months, revenue fell 2% and adjusted earnings per diluted share dropped 29%, and the company guided to fourth-quarter 2025 revenue of $230 million to $260 million.
Q3 2025 revenue was $250.8 million, up from $233.1 million in Q3 2024; excluding divestitures, revenue rose 11%.
GAAP diluted EPS was $0.18 versus a loss of $5.33 a year earlier; adjusted EPS was $0.35, up from $0.32.
Adjusted EBITDA was $37.0 million, up 33% from $27.9 million; GAAP gross margin was 39.5%.
Q4 2025 guidance: revenue of $230 million to $260 million and adjusted EPS of $0.05 to $0.35; the company cited trade policy and tariff risks.
IPG Photonics adopted an amended and restated Executive Severance Plan effective September 30, 2025, changing severance terms, including enhanced change-in-control cash payments and performance-based equity treatment for certain executives. The company also amended its senior executive incentive plan, its CEO's employment agreement, and raised the non-executive Chair's annual cash retainer from $80,000 to $85,000.
Severance Plan amended and restated effective September 30, 2025; Tier One executives receive a lump-sum bonus equal to 200% of target annual bonus after a change in control
Tier Two and Tier Three change-in-control payments are lump-sum, with 150% and 100% of target bonus multiples, respectively
Four Senior Vice Presidents moved from prior employment agreements to the Severance Plan as Tier One Executives, effective September 30, 2025
Non-Executive Chair annual cash retainer increased from $80,000 to $85,000
IPG Photonics reported second quarter 2025 results for the period ended June 30, 2025. Revenue fell 3% year over year to $250.7 million, and GAAP net income dropped 67% to $6.6 million, while the company guided third quarter 2025 revenue to $225 million to $255 million and adjusted EPS to $0.05 to $0.35.
Q2 2025 GAAP operating income was $0.1 million, down from $12.0 million in Q2 2024; GAAP diluted EPS was $0.16 versus $0.45.
Q2 2025 adjusted EPS was $0.30 versus $0.52 a year earlier, and adjusted EBITDA was $31.5 million versus $39.4 million.
Q3 2025 guidance: revenue of $225 million to $255 million, adjusted EPS of $0.05 to $0.35, and adjusted EBITDA of $22 million to $36 million.
During Q2 2025 the company spent $30 million on share repurchases and $15 million on capital expenditures.
IPG Photonics appointed Dr. Paulus Bucher as Senior Vice President, Global Operations effective July 1, 2025, with a $420,000 base salary and a 65% AIP target. He is expected to relocate from Germany to the company's U.S. headquarters once work permission is received.
Appointed July 1, 2025; base salary $420,000 with a 65% target annual incentive bonus
Long-term incentives target equity value of 150% of base salary, split 50% RSUs and 50% PSUs
Severance under the Executive Severance Plan includes 18 months of base salary, or 24 months if terminated within 24 months after a change in control
IPG Photonics entered a $200 million unsecured revolving credit agreement with Bank of America on June 24, 2025, replacing its existing loan agreement that expired June 30, 2025. The facility matures June 24, 2030, and the company may request an increase of up to $100 million under certain conditions.
Facility: $200 million unsecured revolving credit, with $25 million available for letters of credit
Maturity: June 24, 2030; loans can be prepaid without premium or penalty
Pricing: Term SOFR or Base Rate plus a margin based on the Consolidated Net Leverage Ratio
Covenant: quarterly Consolidated Net Leverage Ratio of no more than 3.00 to 1.00
At its May 20, 2025 annual meeting, IPG Photonics stockholders approved the 2025 Incentive Compensation Plan, which replaces the 2006 plan and provides for 2,100,000 newly authorized shares, less one share for each share subject to certain 2006 Plan awards granted after March 10, 2025. Stockholders also elected all ten director nominees, and the Board then reduced its size from eleven members to ten, effective immediately.
2025 Incentive Compensation Plan approved, with 37,563,544 votes for and 843,822 against
Plan provides for 2,100,000 newly authorized shares, less shares tied to certain 2006 Plan awards granted after March 10, 2025
Advisory say-on-pay vote: 36,884,565 votes for and 1,519,754 against
Board reduced from eleven to ten members following the Annual Meeting
IPG Photonics reported first-quarter 2025 revenue of $227.8 million, down 10% from a year earlier, and GAAP net income of $3.8 million, or $0.09 per diluted share, versus $24.1 million, or $0.52, in the prior-year quarter. For the second quarter, the company guided to revenue of $210 million to $240 million and adjusted earnings per diluted share of -$0.05 to $0.25, and said tariffs could delay about $15 million of shipments.
Q1 2025 revenue $227.8 million, down 10% year over year; materials processing sales fell 14%
Q1 GAAP net income $3.8 million ($0.09 per diluted share) vs. $24.1 million ($0.52) a year earlier
Q1 adjusted EPS $0.31 vs. $0.50; adjusted EBITDA $32.7 million vs. $40.3 million
Q2 2025 guidance: revenue $210 million to $240 million; adjusted EBITDA $16 million to $31 million
IPG Photonics amended its consulting agreement with Alexander Ovtchinnikov, its former Senior Vice President and Chief Technology Officer, on April 8, 2025. The amendment extends his consulting services through December 31, 2025, at a monthly fee of $10,000 for the rest of the term. The arrangement is administrative and the filing gives no financial results or guidance.
Amendment dated April 8, 2025 extends consulting services to December 31, 2025
Monthly consulting fee of $10,000 through the remainder of the term
Amends the Services Agreement dated August 15, 2024; full text filed as Exhibit 10.1
IPG Photonics said director Michael C. Child informed the company on March 6, 2025 that he will not stand for re-election at the 2025 annual meeting of stockholders. The filing states his decision is not due to any disagreements with the company on its operations, policies or practices.
Director Michael C. Child informed the company on March 6, 2025 of his decision
He will not stand for re-election at the 2025 annual meeting of stockholders
The filing states there were no disagreements with the company on operations, policies or practices
IPG Photonics reported fourth-quarter 2024 revenue of $234.3 million, down 22% from a year earlier, and diluted EPS of $0.18 versus $0.89. The company guided to first-quarter 2025 revenue of $210 million to $240 million and said its chief accounting officer, Thomas J. Burgomaster, will retire March 1, 2025, succeeded by Mary E. Buttarazzi.
Q4 2024 revenue $234.3 million, down 22% year over year; net income attributable to the company $7.8 million versus $41.4 million
Full-year 2024 operating loss of $208.3 million and net loss of $181.5 million, including a $190.2 million net loss from divestiture and sale of assets
Q1 2025 guidance: revenue $210 million to $240 million; adjusted EPS $0.05 to $0.35; adjusted EBITDA $19 million to $35 million
Mary E. Buttarazzi named Vice President, Corporate Controller and Chief Accounting Officer effective March 1, 2025
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every IPG Photonics filing is on SEC EDGAR ↗. 8-K briefs of other companies →